The biologics and biosimilars market comprises large-molecule drugs, produced using living organisms, that treat complex diseases like cancer, autoimmune disorders, and diabetes. Biologics are original, innovator drugs derived from biological sources, whereas biosimilars are highly similar, lower-cost versions of these biologics that come to market after the original product’s patent...